Back to Trades
Steik Jason Paul
Chief Clinical OfficerCIK 0002078374
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Steik Jason Paul, Chief Clinical Officer, has disclosed $919.5K in transactions — all concentrated in Pennant Group, Inc. (PNTG). Their disclosed trades are heavily weighted toward selling — $0 in buys and $53.7K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 10 | PNTG Pennant Group, Inc. | Steik Jason Paul | Chief Clinical Officer | Sell | $53.7K |
| Mar 12 | PNTG Pennant Group, Inc. | Steik Jason Paul | Chief Clinical Officer | Award | $865.8K |
| Jul 31 | PNTG Pennant Group, Inc. | Steik Jason Paul | Chief Clinical Officer | Other | $0 |
3 filings